Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by diadon1945on Jan 23, 2009 11:34am
508 Views
Post# 15723778

SSS does use STEM CELLS!!!!!!!

SSS does use STEM CELLS!!!!!!!It does not use embryonic stem cells but instead stimulates a persons own stem cells to repair that persons brain. There are no problems with rejection or inflammation as might result from using embryonic stem cells. That is why SSS is so far ahead of the other companies....once the studies begin again there can be some phase II results in three or four months. SSS is years ahead! There has been work on embryonic stem cells outside the U.S. and it is going very slowly.
Bullboard Posts